Daiichi Sankyo Sells Kaketsuken’s Hep B Vaccine in Japan
This article was originally published in PharmAsia News
Executive Summary
Japan’s Chemo-Sero Therapeutic Research Institute (Kaketsuken) has entered into a supply and distribution agreement with Daiichi Sankyo regarding the hepatitis B vaccine Bimmugen.